Events

Human Brain Project Summit 2023
MAR
Tue
28
MAR
Wed
29
MAR
Thu
30
MAR
Fri
31

This was 2 years ago

Location

Marseille, France

PALAIS DU PHARO, Marseille, France
Programmes
Health

The Human Brain Project Summit 2023 provides an open forum for researchers, policy makers, media and public, to discuss exciting scientific results, the latest developments in the project, and the cutting-edge services and tools available on the EBRAINS Research Infrastructure. Many European advances in the field of neurosciences, health and applications in clinical medicine, as well as brain-derived technologies will be presented. It is also meant to be a valuable moment of exchange, discussion, and feedback.

The Summit is an on-site event with theme “Achievements  and future of digital brain research”.

More information, the detailed programme and registration on the event website. Please be aware this is a paying event.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.